Bone Builder Ipriflavone Calcium Supplement

BONE BUILDER

Supplement Facts

Serving Size

2 Tablets

Servings Per Container

60

Amount Per Serving

% Daily Value

Folic Acid

200

mcg

50%

Vitamin B-12 (Cyanocobalamin)

100

mcg

1667%

Calcium (Total)

205

mg

21%

Ipriflavone

300

mg

*

Pyridoxal 5-Phosphate

15

mg

*

*Daily Value not established

INGREDIENTS:  Calcium Citrate Malate Carbonate Complex, Ipriflavone, Dicalcium Phosphate, Stearic Acid, Silica, PhytoZyme proprietary blend (Bromelain, Papain, Alfalfa, Parsley, and vegetable and fruit concentrates from Blueberry, Carrots, Broccoli, Spinach, Cauliflower, Kale, Asparagus, Beet, Chili Pepper, Green Bean, Pea, Sweet Potato, Cucumber, Pumpkin, Snow Pea, Tomato, Watercress, Zucchini, Lima Beans, Maitake Mushroom, Banana, Cantaloupe, Cranberry, Guava, Lemon, Mango, Orange, Papaya, Peach, Pineapple and Grapefruit), Microcrystalline Cellulose, Pyridoxal 5- Phosphate, Croscarmellose Sodium, Magnesium Stearate, Folic Acid and Vitamin B-12 (Cyanocobalamin).

DIRECTIONS:  Two tablets twice a day.

Formulated in the exclusive PhytoZyme™ base of plant enzymes for bioavailability and over 30 synergistic fruit, vegetable and herbal concentrates for "extra" phytonutrient cofactors.

As with all supplements, please consult your physician prior to taking if you are pregnant or attempting to become pregnant, breast-feeding, under a doctor's care or taking prescription medication.

Allergy Information: This product is processed in the same facility that processes products containing fish/shellfish, soy and dairy

This product is not tested on animals.

Suitable for Vegans.

References:
1. Tsutsumi N, Kawashima K, Nagata H, et al. Effects of KCA-098 on bone metabolism: comparison with those of ipriflavone. Jpn J Pharmacol 1994; 65
2. Benvenuti S, Tanini A, Frediani U, et al. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line. J Bone Miner Res 1991; 6
3. Agnusdei D, Gennari C, Bufalino L. Prevention of early postmenopausal bone loss using low doses of conjugated estrogens and the non-hormonal, bone-active drug ipriflavone. Osteoporosis Int 1995; 5
4. Sato Y. Abnormal bone and calcium metabolism in patients after stroke. Arch Phys Med Rehabil 2000 Jan; 81 (1)
5. Bostom AG, Silbershatz IH, Rosenberg IH, et al. Non-fasting plasma total homocysteine levels and all cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 1999; 159:1077-80
6. Agnusdei D, Bufalino L. Efficacy of ipriflavone in established osteoporosis and long-term safety. Calcif Tissue Int 1997;61:S23-S27
7. Krumdieck CL, Prince CW. Mechanisms of homocysteine toxicity on connective tissues:  implications for the morbidity of aging.  J Nutr 2000 Feb;130(2S /syook):354S-368S
8. Miller J, Smith D, Flora L, et al. Calcium absorption from calcium carbonate and a new form of calcium (CCM) in healthy male and female adolescents. Am J Clin Nutr 1988;48:1291–4.

Ipriflavone Calcium Supplement Bone Builder Page

Articles

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Copyright © & Disclaimer 1995-2017 - SJS Distributors , USA. All Rights Reserved.- To Read Please Click Here!

Privacy Policy